These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31378813)

  • 1. Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol).
    Bielinski SJ; St Sauver JL; Olson JE; Larson NB; Black JL; Scherer SE; Bernard ME; Boerwinkle E; Borah BJ; Caraballo PJ; Curry TB; Doddapaneni H; Formea CM; Freimuth RR; Gibbs RA; Giri J; Hathcock MA; Hu J; Jacobson DJ; Jones LA; Kalla S; Koep TH; Korchina V; Kovar CL; Lee S; Liu H; Matey ET; McGree ME; McAllister TM; Moyer AM; Muzny DM; Nicholson WT; Oyen LJ; Qin X; Raj R; Roger VL; Rohrer Vitek CR; Ross JL; Sharp RR; Takahashi PY; Venner E; Walker K; Wang L; Wang Q; Wright JA; Wu TJ; Wang L; Weinshilboum RM
    Int J Epidemiol; 2020 Feb; 49(1):23-24k. PubMed ID: 31378813
    [No Abstract]   [Full Text] [Related]  

  • 2. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort.
    Swanson KM; Zhu Y; Rojas RL; St Sauver JL; Bielinski SJ; Jacobsen DJ; Visscher SL; Wang L; Weinshilboum R; Borah BJ
    PLoS One; 2020; 15(5):e0233316. PubMed ID: 32428022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Promise of Pharmacogenomics: Genetic variation can be used to individualize drug therapy, and is an integral component of genomic medicine.
    Am J Med Genet A; 2019 Dec; 179(12):2324-2325. PubMed ID: 31709748
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics: Precision Medicine and Drug Response.
    Weinshilboum RM; Wang L
    Mayo Clin Proc; 2017 Nov; 92(11):1711-1722. PubMed ID: 29101939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right drug-right patient-right time: personalized medicine coalition.
    Abrahams E
    Clin Transl Sci; 2008 May; 1(1):11-2. PubMed ID: 20443813
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: A review.
    Vaidhya A; Ghildiyal K; Rajawat D; Nayak SS; Parida S; Panigrahi M
    Anim Genet; 2024 Feb; 55(1):3-19. PubMed ID: 37990577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Medicine in Primary Care.
    Hajek C
    S D Med; 2017 Spec; Spec No():62-65. PubMed ID: 28817866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Cardiovascular Medicine: State of Genetic Testing.
    Giudicessi JR; Kullo IJ; Ackerman MJ
    Mayo Clin Proc; 2017 Apr; 92(4):642-662. PubMed ID: 28385198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stakeholder analysis in pharmacogenomics and genomic medicine in Greece.
    Mitropoulou C; Mai Y; van Schaik RH; Vozikis A; Patrinos GP
    Public Health Genomics; 2014; 17(5-6):280-6. PubMed ID: 25228172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacogenomics : a toolbox to improve drug prescription].
    Jaccard E; Redin C; Girardin F; Waeber G; Fellay J; Vollenweider P
    Rev Med Suisse; 2020 Nov; 16(716):2259-2263. PubMed ID: 33237643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Going to the negative: genomics for optimized medical prescription.
    Gibson G
    Nat Rev Genet; 2019 Jan; 20(1):1-2. PubMed ID: 30348998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenomics - a cornerstone of Precision Medicine. Genomic Medicine Sweden analyses genotypes associated with serious drug toxicity or therapeutic failure].
    Eliasson E; Wadelius M
    Lakartidningen; 2021 May; 118():. PubMed ID: 33973222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Online Cancer Genomics Databases to Provide Teaching Resources for Pharmacy Education.
    Pasupuleti D; Nguyen T; Nahta R
    Am J Pharm Educ; 2022 Nov; 86(9):ajpe8683. PubMed ID: 34507956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics implementation and multidisciplinary genomics collaboration: Real-world experience from Geisinger.
    Uber R; Wright E
    Am J Health Syst Pharm; 2022 Jun; 79(13):1038-1041. PubMed ID: 35279024
    [No Abstract]   [Full Text] [Related]  

  • 17. How close are we to individualized medicine for Parkinson's disease?
    Kim HJ; Jeon B
    Expert Rev Neurother; 2016 Jul; 16(7):815-30. PubMed ID: 27105072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
    Blix A
    Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
    Bush WS; Crosslin DR; Owusu-Obeng A; Wallace J; Almoguera B; Basford MA; Bielinski SJ; Carrell DS; Connolly JJ; Crawford D; Doheny KF; Gallego CJ; Gordon AS; Keating B; Kirby J; Kitchner T; Manzi S; Mejia AR; Pan V; Perry CL; Peterson JF; Prows CA; Ralston J; Scott SA; Scrol A; Smith M; Stallings SC; Veldhuizen T; Wolf W; Volpi S; Wiley K; Li R; Manolio T; Bottinger E; Brilliant MH; Carey D; Chisholm RL; Chute CG; Haines JL; Hakonarson H; Harley JB; Holm IA; Kullo IJ; Jarvik GP; Larson EB; McCarty CA; Williams MS; Denny JC; Rasmussen-Torvik LJ; Roden DM; Ritchie MD
    Clin Pharmacol Ther; 2016 Aug; 100(2):160-9. PubMed ID: 26857349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.